Improved method for screening gene knockout porcine fetal fibroblasts
By designing sgRNA for Dock8 gene and combining electrotransfer and flow sorting of the CRISPR-Cas9 system, subclonal culture and PCR identification were further carried out, which solved the problems of low gene editing efficiency and low donor cell positive rate in the prior art. , efficient knockout operation and shortened cell preparation cycle.
Patent Information
- Application Number
- CN202310625285.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2023-05-30
- Publication Date
- 2024-12-06
AI Technical Summary
In the prior art, the gene editing and targeting efficiency is not high, the donor cell positive rate is relatively low, and the cell cycle of screening positive donors is long, especially the growth rate of pig fetal fibroblasts is slow, which is prone to aging, which affects subsequent cloning. Passing.
采用改良方法,包括设计并合成针对Dock8基因的sgRNA,使用CRISPR-Cas9系统进行电转后进行流式分选富集,进一步进行亚克隆培养和挑选,结合PCR鉴定以提高基因敲除细胞的阳性率 .
The positive rate of cell clones was significantly improved, and the positive rate of gene knockout cell clones reached 88%, shortening the donor cell preparation cycle and improving the efficiency of gene editing operations.
Smart Images

Figure CN119082208A_ABST
Abstract
Description
Technical Field The invention relates to the field of animal genetic engineering and genetic modification, and in particular to an improved method for screening gene knockout pig fetal fibroblasts. Background Art
[0002] The CRISPR / Cas system is an acquired immune system in bacteria and archaea that specifically cuts exogenous genetic material through RNA-mediated cutting. The type II CRISPR / Cas system, namely CRISPR / Cas9, has been proven to be widely used for efficient cutting of any given DNA in vivo and in vitro. At the same time, the system can be used for site-directed mutagenesis and site-directed insertion of the genome. Compared with traditional ZFN and TALEN technologies, CRISPR / Cas9 has the advantages of high efficiency, less sequence selection restrictions, simple construction process, and the ability to target multiple genes at the same time. The biggest disadvantage of CRISPR / Cas9 is its off-target effect. Currently, many studies have shown that this off-target effect can be controlled by certain technical means.
[0003] Chinese patent document CN111549058A discloses a method for achieving gene knockout in porcine fetal fibroblasts using the CRISPR / Cas9 system. The method comprises constructing a Cas9 / sgRNA eukaryotic expression vector and an RGS-CR dual fluorescence alternative reporter vector, co-transfecting the Cas9 / sgRNA eukaryotic expression vector and the RGS-CR reporter vector into 293T cells, screening the most efficient sgRNA sequence, and then electroporating the screened Cas9 / sgRNA plasmid into porcine fetal fibroblasts to achieve knockout. The final mutation rate was measured to be 15.79%. It can be seen that screening only the sgRNA design is insufficient to increase the acquisition rate of homozygous donor cells.
[0004] CN111363743A discloses a porcine fetal fibroblast cell line with SCD gene knockout and a construction method thereof, which utilizes green fluorescent protein to improve the Cas9 / sgRNA targeting efficiency through flow sorting, and the cell clone mutation rate reaches 25%.
[0005] CN109679958A discloses sgRNA that specifically recognizes the porcine Tert site, its encoding DNA, and its application. The two sgRNAs designed to specifically recognize the porcine Tert gene can efficiently achieve large-fragment knockout of the porcine Tert gene with the help of the CRISPR / Cas9 gene editing system and the double fluorescence enrichment method, and the knockout efficiency of cell cloning can reach 50%.
[0006] The prior art also discloses a method for rapidly and efficiently generating gene-edited donor cells—RE-DSRNP (reporter RNA enriched dual-sgRNA / CRISPR-Cas9 ribonucleoproteins), which uses reporter RNA probes to enrich gene-edited donor cells edited by dual sgRNA and CRISPR / Cas9. This method is based on the CRISPR / Cas9 system, does not require the introduction of reporter genes, and does not require monoclonal cloning. The RNA probe and flow sorting method improve the targeting efficiency and effectively control the off-target effect of the CRISPR / Cas9 system. The probability of obtaining positive homozygous cloned pigs using this method is 47% (Xu K, Zhang X, Liu Z, Ruan J, Xu C, Che J, Fan Z, Mu Y, Li K. A transgene-free method for rapid and efficient generation of precisely edited pigs without monoclonal selection. Sci China Life Sci. 2022 Aug; 65(8): 1535-1546.) These methods are closely related to the specificity of sgRNA. Usually after transfection or sorting, researchers will perform limiting dilution or single-cell culture on the cells for about 10 days before subculturing the clones to 48-well or 24-well wells and continue culturing them. After the cells are fully grown, the clones will be identified and frozen.
[0007] The existing methods disclosed in the above-mentioned prior art are based on the CRISPR / Cas9 system for gene editing targeting, which has low efficiency, low donor cell positivity rate, and a long time-consuming process for screening positive donor cells. In particular, since porcine fetal fibroblasts are primary cells, after being monocloned, the cells grow slowly and are prone to aging, which has a serious impact on the subsequent cloning and propagation. Summary of the invention
[0008] In view of the low efficiency of gene editing targeting based on the CRISPR / Cas9 system, the low positive rate of donor cells, and the long period of screening positive donor cells, the present invention provides an improved method for screening gene knockout pig fetal fibroblasts, which comprises the following steps: (1) Design and synthesis of sgRNA targeting the target gene; (2) Knockout of the Dock8 gene in porcine fetal fibroblasts; (3) enriching positive cells by flow cytometry; (4) Perform subcloning.
[0009] Furthermore, the step (1) designing and synthesizing sgRNA targeting the target gene specifically comprises the following steps: obtaining a Dock8 sequence in the exon sequence of the target gene, designing a sgRNA1 target sequence and a sgRNA2 target sequence according to the target gene, and synthesizing the sgRNA1 target sequence and the sgRNA2 target sequence into a target sequence of the target gene.
[0010] Furthermore, the sgRNA1 target sequence is SEQ ID No.1.
[0011] Furthermore, the sgRNA2 target sequence is SEQ ID No.2.
[0012] Furthermore, the step (2) of knocking out the Dock8 gene in pig fetal fibroblasts comprises the following steps: mixing the synthesized sgRNA with the Cas9 protein, and then electroporating the mixture together with the CRISPR-Cas9 tracrRNA into pig fetal fibroblasts.
[0013] Furthermore, the subcloning in step (4) comprises the following steps: A. Subclone culture: After culturing the cells sorted in step (3) for 24-48 hours, subclone them into 6-well plates at a density of 400-600 cells / well and continue culturing for 4-5 days; B. Subclone selection: Use cloning rings to select subclones with good growth status and place them in 96-well plates for 2-3 days; C. Seed preservation and PCR identification: After the subclones with a confluence of 90% are subcultured to a 24-well plate, the culture is continued for 2-3 days, and the subclones in the 24-well plate are preserved and identified by PCR.
[0014] Furthermore, the step (3) is to perform flow cytometry to enrich positive cells, and the specific process includes the following steps: the porcine fetal fibroblasts obtained in step (2) are used for flow cytometry, and the positive cells are enriched and cultured in a 96-well plate.
[0015] Furthermore, the step (2) knockout of the Dock8 gene in porcine fetal fibroblasts comprises the following steps: adding the prepared antibiotic-free culture medium to a cell culture plate and preheating it in an incubator in advance; incubating 4-6 μg of the synthesized sgRNA1 and sgRNA2 with 5-6 μg of Cas9 protein at room temperature, then adding 0.01-0.1 nmol of CRISPR-Cas9tracrRNA to the mixture, adding the mixture to the porcine fetal fibroblasts that have been resuspended in the electroporation mixture for electroporation, and adding the electroporated cells to a 6-well plate for culture.
[0016] The present invention has the following beneficial effects: the present invention further subclones the gene-edited cells sorted and enriched by the RE-DSRNP method, and the selected subclone cell lines can usually be subjected to PCR and sequencing identification within 10-14 days, which significantly improves the positive rate of cell cloning, and the positive rate of gene knockout cell clones is 88%, and the gene editing operation can be efficiently performed, and the preparation cycle of donor cells is shorter than that of the monoclonal screening method. BRIEF DESCRIPTION OF THE DRAWINGS
[0018] Figure 1 A flow chart of the method for screening gene knockout pig fetal fibroblasts according to the present invention is provided.
[0019] Figure 2 The PCR identification results of cells enriched by flow cytometry are provided.
[0020] Figure 3 A picture of cell clones in a 6-well plate after 5 days of subcloning is provided.
[0021] Figure 4 Provides PCR electrophoresis identification of cell clones after subcloning. DETAILED DESCRIPTION
[0022] The examples are provided to better illustrate the content of the present invention, but the content of the present invention is not limited to the examples. Therefore, those skilled in the art can make non-essential improvements and adjustments to the implementation scheme according to the above content of the invention, which still fall within the protection scope of the present invention.
[0023] The subcloning described in the present invention is: dividing several regions from a cloned DNA fragment, cloning them into new vectors respectively, and obtaining a series of new recombinants.
[0024] The enrichment mentioned in the present invention is an operation step of collecting the trace elements to be determined from a large amount of parent material into a smaller volume, thereby increasing the content thereof to above the lower limit of determination.
[0025] The present invention provides a method for achieving gene knockout in porcine fetal fibroblasts using the CRISPR / Cas9 system, wherein a specific sgRNA is mixed with the Cas9 protein and then with 0.01-1 nmol Alt-R TM CRISPR-Cas9 tracrRNA (ATTO TM 550, Integrated DNA Technologies) were co-transfected into porcine fetal fibroblasts (PEF) to obtain gene-knockout PEF cells, and the transfected cells were further enriched by flow cytometry, and after further subcloning, gene-knockout PEF cells were obtained by PCR identification.
[0026] Example 1 To facilitate the understanding of the technical solution of the present invention, a method of the present invention for achieving gene knockout in porcine fetal fibroblasts using the CRISPR / Cas9 system is further described below in conjunction with specific experimental examples.
[0027] A method for knocking out the Dock8 gene in porcine fetal fibroblasts using the CRISPR / Cas9 system: The following steps are involved: (1) Determination of the target sequence of the target gene: The sequence of Dock8 was found in the exon sequence of the target gene, and the sgRNA1 target sequence and sgRNA2 target sequence were designed and synthesized according to the target gene. The sgRNA1 target sequence was 5'-CCTAAAAGCCGACCAGCCGCCGG-3' (SEQ ID No. 1), and the sgRNA2 target sequence was 5'-CCGGAGCCGTCGAGTGTGAAGGG-3' (SEQ ID No. 2). The synthesized target sequence and its complementary sequence were dissolved in water to 1 μg / μL respectively.
[0028] (2)Use Nucleofector TM 2b electroporation system (Lonza) was used to knock out the Dock8 gene in PEF cells (porcine fetal fibroblasts from the experimental pig base of the Institute of Bioengineering, Chongqing Academy of Animal Husbandry Sciences): 2 mL of antibody-free KnockOut was added to each well of a 6-well plate. TM DMEM medium (containing 20% FBS, Gibco) was preheated in a 37°C incubator. 5 μg of sgRNA1 target sequence and 5 μg of sgRNA2 target sequence were incubated with 6 μg of Cas9 protein (M0646, New England Biolabs) at room temperature for 15 min, and then 0.1 nmol of Alt-R TM CRISPR-Cas9 tracrRNA (ATTO TM 550) and then the mixture was added to the PEF cells resuspended in the electroporation mixture (VPI-1002, Lonza) for electroporation. The amount of PEF cells was 1×10 6 The electroporated cells were added to a 6-well plate and cultured for 24 h.
[0029] (3) Flow cytometry enrichment: PEF cells after 24 h of culture were used for flow cytometry to enrich ATTO TM 550 positive cells were added to 96-well plates (15%) and cultured at 38.5°C for 24 h.
[0030] (4) Subclone culture: The PEF enriched by flow cytometry in the 96-well culture was divided into two parts, one of which was used for PCR identification ( Figure 4 ), and the other part was subcloned into 6-well plates at a density of 500 cells / well, and cultured for 4-5 days, with the medium changed every other day.
[0031] (5) Selection of subclones: Use a cloning ring to select subclones with good growth status in the 6-well plate and transfer them to a 96-well plate. Change the medium on the next day and continue culturing for 2-3 days.
[0032] (6) Subclone culture: Subclones with a confluence of 90% were cultured in 24-well plates and cultured for 2-3 days. Subclones in the 24-well plates were preserved and identified by PCR.
[0033] (7) PCR detection of subclone cell positive rate: PEF genomic DNA was extracted using a genomic DNA extraction kit (Tiangen DP316); a DNA fragment of about 561 bp near the target site was amplified using PCR upstream primers and downstream primers. The PCR system was: Premix Taq TM 12.5 μL, 0.2 μL of upstream and downstream primers (F: GAAGTTTCCAAACGCGACTGACAGA, R: AAGCACCTCTGGTGAGAACTTTGAG), 40 ng of genomic DNA, and deionized water to 20 μL. The amplification program was: 98°C 30 s, 35× (98°C 10 s, 58°C 30 s, 72°C 1 min), 72°C 5 min, 2% agarose gel electrophoresis, and the results of PEF cell clone PCR detection were shown in Figure 4 Among the 9 clones, 8 were positive clones, and the positive rate of gene knockout cell clones was 88%.
[0034] In addition, it should be understood that although the present specification is described according to implementation modes, not every implementation mode contains only one independent technical solution. This description of the specification is only for the sake of clarity. Those skilled in the art should regard the specification as a whole. The technical solutions in each embodiment may also be appropriately combined to form other implementation modes that can be understood by those skilled in the art.
Claims
1. An improved method for screening gene knockout pig fetal fibroblasts, Features: The method comprises the following steps: (1) Design and synthesis of sgRNA targeting target genes; (2) Knockout of the Dock8 gene in porcine fetal fibroblasts; (3) Flow cytometry to enrich positive cells; (4) Perform subcloning.
2. The improved method for screening gene knockout pig fetal fibroblasts according to claim 1, Features: The step (1) designing and synthesizing sgRNA targeting the target gene specifically comprises the following steps: obtaining a Dock8 sequence in the exon sequence of the target gene, designing a sgRNA1 target sequence and a sgRNA2 target sequence according to the target gene, and synthesizing the target sequence of the target gene using the sgRNA1 target sequence and the sgRNA2 target sequence.
3. The improved method for screening gene knockout pig fetal fibroblasts according to claim 2, Features: The sgRNA1 target sequence is SEQ ID No.
1.
4. The improved method for screening gene knockout pig fetal fibroblasts according to claim 2 or 3, Features: The sgRNA2 target sequence is SEQ ID No.
2.
5. The improved method for screening gene knockout pig fetal fibroblasts according to any one of claims 1 to 4, Features: The step (2) of knocking out the Dock8 gene in pig fetal fibroblasts comprises the following steps: mixing the synthesized sgRNA with the Cas9 protein, and then electroporating the mixture together with the CRISPR-Cas9 tracrRNA into pig fetal fibroblasts.
6. The improved method for screening gene knockout porcine fetal fibroblasts according to any one of claims 1 to 5, Features: The subcloning step (4) comprises the following steps: A. Subclone culture: After culturing the cells sorted in step (3) for 24-48 hours, subclone them into 6-well plates at a density of 400-600 cells / well and continue culturing for 4-5 days; B. Subclone selection: Use cloning rings to select subclones with good growth status and place them in 96-well plates for 2-3 days; C. Seed preservation and PCR identification: After the subclones with a confluence of 90% are subcultured to a 24-well plate, the culture is continued for 2-3 days, and the subclones in the 24-well plate are preserved and identified by PCR.
7. The improved method for screening gene knockout pig fetal fibroblasts according to claim 6, Features: The step (3) is to perform flow cytometry to enrich positive cells. The specific process includes the following steps: the porcine fetal fibroblasts obtained in step (2) are used for flow cytometry, and the positive cells are enriched and cultured in a 96-well plate.
8. The improved method for screening gene knockout pig fetal fibroblasts according to claim 7, Features: The step (2) knockout of the Dock8 gene in porcine fetal fibroblasts specifically comprises the following steps: adding the prepared antibiotic-free culture medium to a cell culture plate and preheating it in an incubator in advance; incubating 4-6 μg of the synthesized sgRNA1 and sgRNA2 with 5-6 μg of Cas9 protein at room temperature, then adding 0.01-0.1 nmol of CRISPR-Cas9 tracrRNA to the mixture, adding the mixture to the porcine fetal fibroblasts that have been resuspended in the electroporation mixture for electroporation, and adding the electroporated cells to a 6-well plate for culture.
Citation Information
Cited By
Construction method and application of tool pig with controllable immortalized cell line
CN122303326A
